- United Kingdom
- /
- Aerospace & Defense
- /
- LSE:AVON
Avon Technologies Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Avon Technologies (LON:AVON) Full Year 2024 Results
Key Financial Results
- Revenue: US$275.0m (up 13% from FY 2023).
- Net income: US$3.00m (up from US$16.4m loss in FY 2023).
- Profit margin: 1.1% (up from net loss in FY 2023).
- EPS: US$0.10 (up from US$0.55 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Avon Technologies Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 4.0%. Earnings per share (EPS) missed analyst estimates by 24%.
The primary driver behind last 12 months revenue was the Avon Protection segment contributing a total revenue of US$145.6m (53% of total revenue). Notably, cost of sales worth US$168.2m amounted to 61% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$49.7m (48% of total expenses). Explore how AVON's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Aerospace & Defense industry in the United Kingdom.
Performance of the British Aerospace & Defense industry.
The company's share price is broadly unchanged from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 1 warning sign for Avon Technologies you should be aware of.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About LSE:AVON
Avon Technologies
Provides respiratory and head protection products for the military and first responder markets in Europe and the United States.
Excellent balance sheet with reasonable growth potential.
